Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death

FASEB Journal

Volumn 26, Issue 9, 2012, Pages 3854-3861

  Cronier, Sabrina ^a   Carimalo, Julie ^c,d   Schaeffer, Brigitte ^b   Jaumain, Emilie ^a   Béringue, Vincent ^a   Miquel, Marie Christine ^c   Laude, Hubert ^a   Peyrin, Jean Michel ^a,c  

^a INRA Institut National de la Recherche Agronomique   (France)

^b UR341 National Agronomical Research Institute (INRA)   (France)

^c CNRS   (France)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Astrocyte; Neurodegeneration; Primary culture; Scrapie

Indexed keywords

GLUTAMIC ACID; PRION PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; COCULTURE; CONTROLLED STUDY; ENVIRONMENTAL STRESS; HUMAN; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; ASTROCYTES; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, TRANSGENIC; NEURITES; NEURONS; PRIONS;

MUS MUSCULUS; OVIS; OVIS ARIES;

EID: 84865786047     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-201772     Document Type: Article

References (48)

1. Collinge, J. (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550
2. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13363-13383
3. Silveira, J. R., Caughey, B., and Baron, G. S. (2004) Prion protein and the molecular features of transmissible spongiform encephalopathy agents. Curr. Top. Microbiol. Immunol. 284, 1-50
4. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343
5. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M., and Weissmann, C. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347
6. Caughey, B., and Lansbury, P. T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267-298
7. Brown, D. R. (2002) Mayhem of the multiple mechanisms: modelling neurodegeneration in prion disease. J. Neurochem. 82, 209-215
8. Gavin, R., Braun, N., Nicolas, O., Parra, B., Urena, J. M., Mingorance, A., Soriano, E., Torres, J. M., Aguzzi, A., and del Rio, J. A. (2005) PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc. FEBS Lett. 579, 4099-4106
9. Brown, D. R., Herms, J., and Kretzschmar, H. A. (1994) Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5, 2057-2060
10. Kunz, B., Sandmeier, E., and Christen, P. (1999) Neurotoxicity of prion peptide 106-126 not confirmed. FEBS Lett. 458, 65-68
11. Simoneau, S., Rezaei, H., Sales, N., Kaiser-Schulz, G., Lefebvre- Roque, M., Vidal, C., Fournier, J. G., Comte, J., Wopfner, F., Grosclaude, J., Schatzl, H., and Lasmezas, C. I. (2007) In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog. 3, e125
12. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., Caughey, B., Masliah, E., and Oldstone, M. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439
13. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P. C., Brandner, S., and Collinge, J. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874
14. Raeber, A. J., Race, R. E., Brandner, S., Priola, S. A., Sailer, A., Bessen, R. A., Mucke, L., Manson, J., Aguzzi, A., Oldstone, M. B., Weissmann, C., and Chesebro, B. (1997) Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16, 6057-6065
15. Jeffrey, M., Goodsir, C. M., Race, R. E., and Chesebro, B. (2004) Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann. Neurol. 55, 781-792
16. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132
17. Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Muller, V., Krishnan, R., Vabulas, R. M., Kretzschmar, H. A., Lindquist, S., Hartl, F. U., Multhaup, G., Winklhofer, K. F., and Tatzelt, J. (2011) The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057-2070
18. Lefebvre-Roque, M., Kremmer, E., Gilch, S., Zou, W. Q., Feraudet, C., Gilles, C. M., Sales, N., Grassi, J., Gambetti, P., Baron, T., Schatzl, H., and Lasmezas, C. I. (2007) Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion 1, 198-206
19. Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sanchez-Alavez, M., Sugama, S., DeGiorgio, L. A., Volpe, B. T., Wiseman, E., Abalos, G., Masliah, E., Gilden, D., Oldstone, M. B., Conti, B., and Williamson, R. A. (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516
20. Schneider, B., Pietri, M., Pradines, E., Loubet, D., Launay, J. M., Kellermann, O., and Mouillet-Richard, S. (2011) Understanding the neurospecificity of Prion protein signaling. Front. Biosci. 16, 169-186
21. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., Chiesa, R., Gobbi, M., Salmona, M., and Forloni, G. (2010) Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U. S. A. 107, 2295-2300
22. Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., and Aguzzi, A. (2010) Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314
23. Klohn, P. C., Farmer, M., Linehan, J. M., O'Malley, C., Fernandez de Marco, M., Taylor, W., Farrow, M., Khalili-Shirazi, A., Brandner, S., and Collinge, J. (2012) PrP antibodies do not trigger mouse hippocampal neuron apoptosis. Science 335, 52
24. Cronier, S., Laude, H., and Peyrin, J. M. (2004) Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc. Natl. Acad. Sci. U. S. A. 101, 12271-12276
25. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Prusiner, S. B., Aguet, M., and Weissmann, C. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582
26. Laude, H., Vilette, D., Le Dur, A., Archer, F., Soulier, S., Besnard, N., Essalmani, R., and Vilotte, J. L. (2002) New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives. C. R. Biol. 325, 49-57
27. Fischer, M., Rulicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A., and Weissmann, C. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264
28. Beringue, V., Le Dur, A., Tixador, P., Reine, F., Lepourry, L., Perret-Liaudet, A., Haik, S., Vilotte, J. L., Fontes, M., and Laude, H. (2008) Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One 3, e1419
29. Cronier, S., Beringue, V., Bellon, A., Peyrin, J. M., and Laude, H. (2007) Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures. J. Virol. 81, 13794-13800
30. Langevin, C., Andreoletti, O., Le Dur, A., Laude, H., and Beringue, V. (2011) Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model. Neurobiol. Dis. 41, 219-225
31. Paquet, S., Langevin, C., Chapuis, J., Jackson, G. S., Laude, H., and Vilette, D. (2007) Efficient dissemination of prions through preferential transmission to nearby cells. J. Gen. Virol. 88, 706-713
32. Custer, S. K., Garden, G. A., Gill, N., Rueb, U., Libby, R. T., Schultz, C., Guyenet, S. J., Deller, T., Westrum, L. E., Sopher, B. L., and La Spada, A. R. (2006) Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat. Neurosci. 9, 1302-1311
33. Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J. R., Burghes, A. H., and Kaspar, B. K. (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 29, 824-828
34. Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., and Przedborski, S. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622
35. Raymond, G. J., Hope, J., Kocisko, D. A., Priola, S. A., Raymond, L. D., Bossers, A., Ironside, J., Will, R. G., Chen, S. G., Petersen, R. B., Gambetti, P., Rubenstein, R., Smits, M. A., Lansbury, P. T., Jr., and Caughey, B. (1997) Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388, 285-288
36. Horiuchi, M., Priola, S. A., Chabry, J., and Caughey, B. (2000) Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc. Natl. Acad. Sci. U. S. A. 97, 5836-5841
37. Priola, S. A., Caughey, B., Race, R. E., and Chesebro, B. (1994) Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J. Virol. 68, 4873-4878
38. Westergard, L., Christensen, H. M., and Harris, D. A. (2007) The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 1772, 629-644
39. Sakudo, A., and Ikuta, K. (2009) Prion protein functions and dysfunction in prion diseases. Curr. Med. Chem. 16, 380-389
40. Goold, R., Rabbanian, S., Sutton, L., Andre, R., Arora, P., Moonga, J., Clarke, A. R., Schiavo, G., Jat, P., Collinge, J., and Tabrizi, S. J. (2011) Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat. Commun. 2, 281
41. Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R., and Collinge, J. (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540-542
42. Dong, X. X., Wang, Y., and Qin, Z. H. (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 30, 379-387
43. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112
44. Milhavet, O., McMahon, H. E., Rachidi, W., Nishida, N., Katamine, S., Mange, A., Arlotto, M., Casanova, D., Riondel, J., Favier, A., and Lehmann, S. (2000) Prion infection impairs the cellular response to oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 97, 13937-13942
45. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., and Selkoe, D. J. (2011) Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. U. S. A. 108, 5819-5824
46. Schengrund, C. L. (2010) Lipid rafts: keys to neurodegeneration. Brain Res. Bull. 82, 7-17
47. Nygaard, H. B., and Strittmatter, S. M. (2009) Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch. Neurol. 66, 1325-1328
48. Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W., Menendez-Benito, V., Dantuma, N. P., Portis, J. L., Collinge, J., and Tabrizi, S. J. (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell 26, 175-188